MARA's bottom line is dominated by mark-to-market swings on its Bitcoin holdings, which drove most of last quarter's $611.3 ...
GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / November 2, 2026 / Moolec Science SA in Voluntary Liquidation (Nasdaq:MLEC) (the "Company") today announced that it received a Staff Delisting ...
NORTHAMPTON, MA / ACCESS Newswire / November 2, 2026 / Last month, CVS Health, Aetna, and Oak Street colleagues in Columbus, Ohio, celebrated the residents of Bretton Woods with an Ohio State-themed ...
STOCKHOLM, SE / ACCESS Newswire / November 3, 2026 / Vicore Pharma Holding AB (STO:VICO)(NASDAQ:VCRE), a biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, ...
Realty Income delivered third-quarter AFFO of $1.12 per share, exactly matching the Earnings Whisper number and a penny above the $1.11 consensus. Revenue of $1.622 billion beat expectations by 2.6% ...
monday.com heads into its third-quarter report in the middle of a deliberate reinvention. Three months ago, management cut roughly a fifth of its workforce, leaned hard into AI products and pricing, ...
With Alphabet GOOGL) and Amazon AMZN) reporting negative free cash flow amid massive AI infrastructure spending, free cash flow (FCF) is becoming one of the most important metrics for evaluating ...
Management reaffirmed 2026 non-GAAP guidance of $4.28 to $4.40. That is the central tension: a reaffirmation quarter that came in light, with the softness concentrated in the regulated utility that is ...
AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report third quarter 2026 ...
Dorman Products, Inc. (NASDAQ:DORM) continues to expand its aftermarket product offerings with innovative repair solutions engineered to address common points of failure in original equipment ...
The live and archived webcast can also be accessed by visiting the Nuvectis Pharma website on the Events and Presentations section of the Investor Relations page. A replay of the webcast will be ...
Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results